Phoenix Life Sciences International (OTCPK:PLSI) - Stock Price, News & Analysis

PLSI Stock Overview

Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. More details

PLSI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($1K)

Shares are highly illiquid

Latest financial reports are more than a year old

Phoenix Life Sciences International Limited Competitors

Item 9 Labs

OTCPK:INLB

US$701.0

BZAM

OTCPK:BZAM.F

US$270.0

Lucy Scientific Discovery

OTCPK:LSDI.F

US$882.0

Clever Leaves Holdings

OTCPK:CLVR

US$1.0

Price History & Performance

Summary of all time highs, changes and price drops for Phoenix Life Sciences International
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.82
52 Week Low	US$0.0001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-99.97%
5 Year Change	-100.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	PLSI	US Pharmaceuticals	US Market
7D	0%	4.2%	2.0%
1Y	n/a	13.7%	32.4%

Return vs Industry: Insufficient data to determine how PLSI performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how PLSI performed against the US Market.

Price Volatility

Is PLSI's price volatile compared to industry and market?
PLSI volatility
PLSI Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.9%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PLSI has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PLSI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2009	n/a	Willis Victory	www.phoenixlife.co

Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams.

Phoenix Life Sciences International Limited Fundamentals Summary

How do Phoenix Life Sciences International's earnings and revenue compare to its market cap?
PLSI fundamental statistics
Market cap	US$1.40k
Earnings (TTM)	-US$3.12m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is PLSI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PLSI income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$3.12m
Earnings	-US$3.12m

Last Reported Earnings

Feb 28, 2019

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PLSI perform over the long term?

See historical performance and comparison